Similar results were obtained when we tested the combined effect of MDK/ALK axis inhibitors and cannabinoids, a novel family of potential anticancer agents 39, 40 that have been shown to synergize with ALK inhibitors in differentiated glioma cells 13, 39, 40. This evidence concerns the gene MDK and central nervous system cancer.